Intra-tumoral injection of doxorubicin (adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects

✍ Scribed by Hitoshi Idani; Junji Matsuoka; Tatsuji Yasuda; Kazuko Kobayashi; Noriaki Tanaka

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: French
• Weight: 254 KB
• Volume: 88
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/1097-0215(20001115)88:4<645::aid-ijc20>3.0.co;2-4